Cargando…
Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
Gastrointestinal cancer (GI) is a major health problem. Patients with gastric, pancreatic, colorectal, bile duct and gall bladder cancer often have advanced disease at the time of diagnosis and are generally difficult to cure, resulting in a dismal prognosis for most patients. Inflammation plays an...
Autores principales: | Vainer, Noomi, Dehlendorff, Christian, Johansen, Julia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049875/ https://www.ncbi.nlm.nih.gov/pubmed/30038723 http://dx.doi.org/10.18632/oncotarget.25661 |
Ejemplares similares
-
Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020) -
Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022) -
Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022) -
Choledochal Cyst with Carcinoma of the Intrahepatic Bile Ducts and Pancreatic Ducts
por: Dexter, D.
Publicado: (1957) -
Primary Bile Duct Perforation Associated with Pancreatitis
por: Gerrard, Adam Daniel, et al.
Publicado: (2018)